LivingGLP1
Study S000923

A Clinical Efficacy Study of Mazdutide in the Treatment of Polycystic Ovary Syndrome

Registration

Registration
NCT06519656
Study type
INTERVENTIONAL
Phase
PHASE1; PHASE2
Masking
NONE
Status
COMPLETED
Enrollment
43
Start
2024-10-21
Primary completion
2026-09-01
Lead sponsor
Shanghai Zhongshan Hospital
Conditions
Polycystic Ovary Syndrome
Interventions
DRUG:Mazdutide
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Free Androgen Index (FAI) [24 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.